See What HealthDay Can Do For You
Contact Us

Nov. 2005 Briefing – Ophthalmology

Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for November 2005. This roundup includes the latest journal articles and updates from government agencies, including the FDA, NIH, and agencies from the UK and Canada, that are the most likely to affect clinical practice.

OTC Eye Drop Maker Halted Due to FDA Violations

TUESDAY, Nov. 29 (HealthDay News) -- The U.S. Food and Drug Administration announced Tuesday that MBI Distributing, Inc., also known as Molecular Biologics, has signed a consent decree requiring it to stop making eye drops and other drugs until it corrects problems in its Benicia, Calif., facility.

More Information

Devices Improve Night Vision in Retinitis Pigmentosa

WEDNESDAY, Nov. 23 (HealthDay News) -- Low-vision night mobility devices benefit patients who have severe night blindness associated with retinitis pigmentosa, according to a recent study published in the Journal of Rehabilitation Research & Development. Many patients are so severely affected that they use a sighted guide or eliminate outside trips after dark.

Full Text (payment may be required)

FDA Announces Recall of GenTeal Gel Eyedrops

WEDNESDAY, Nov. 23 (HealthDay News) -- The U.S. Food and Drug Administration announced Tuesday a voluntary recall of seven lots of two products, GenTeal Gel and GenTeal GelDrops, due to a lack of sterility assurance. Both are non-prescription eyedrops meant to relieve dryness of the eye.

More Information -- FDA
More Information -- Novartis

FDA Issues Warning About Flomax and Cataract Surgery

WEDNESDAY, Nov. 23 (HealthDay News) -- The U.S. Food and Drug Administration warned Tuesday that men taking the drug Flomax (tamsulosin) for benign prostatic hyperplasia, or those who have taken it in the past, could experience problems during cataract surgery.

More Information -- FDA
More Information -- Boehringer Ingelheim

Eye Shots More Successful in Diabetics with Macular Edema

MONDAY, Nov. 21 (HealthDay News) -- Diabetic patients are more likely to benefit from intravitreal injection of triamcinolone acetonide if they have pronounced macular edema and less likely to benefit if they have macular ischemia and a high preoperative best-corrected visual acuity, according to a study in the October issue of the Archives of Ophthalmology.

Abstract
Full Text (payment may be required)

Support System Increases Cataract Surgery Rates

MONDAY, Nov. 14 (HealthDay News) -- An organized support system to help nursing home residents schedule cataract surgery and transport them to and from the hospital significantly increases uptake rates, according to a study published in the November issue of the Archives of Ophthalmology.

Abstract
Full Text (payment may be required)

Corneal Blindness Surgery Provides Long-Term Benefits

MONDAY, Nov. 14 (HealthDay News) -- A modified osteo-odonto-keratoprosthesis (OOKP) surgery for corneal blindness may provide an anatomically stable prosthesis and improved vision, according to a study published in the October issue of the Archives of Ophthalmology.

Abstract
Full Text (payment may be required)

Nasal Steroids May Contribute to Glaucoma Eye Pressure

THURSDAY, Nov. 10 (HealthDay News) -- Glaucoma patients who discontinue use of nasal steroids may experience a significant reduction in intraocular pressure (IOP), according to a study in the November issue of the Journal of Allergy and Clinical Immunology. Some patients were able to alleviate the need for additional glaucoma drugs or surgery simply by stopping use of the corticosteroids, which are used to control allergic rhinitis or other nasal symptoms.

Abstract
Full Text (payment may be required)

Presurgical Radiation Boosts Survival After Eye Melanoma

THURSDAY, Nov. 10 (HealthDay News) -- Radiotherapy of an eye before enucleation improves survival for patients with uveal melanoma, according to a study in the October issue of the Archives of Ophthalmology.

Abstract
Full Text (payment may be required)

U.S. Leads Six-Nation Survey of Medical Errors

THURSDAY, Nov. 3 (HealthDay News) -- The United States leads five other developed nations in the number of medical mistakes, medication errors or inaccurate or delayed lab results, according to an international patient survey conducted by The Commonwealth Fund.

More Information
Full Text (payment may be required)

Eye Exams Help Preserve Elderly Vision

THURSDAY, Nov. 3 (HealthDay News) -- Regular eye examinations help elderly patients preserve their vision and participate in daily life, according to a study in the November issue of the Journal of the American Geriatrics Society. An additional year with an eye examination cuts the probability that a patient will be unable to read newsprint or will have onset of low vision or blindness.

Abstract
Full Text (payment may be required)

FDA Announces New Electronic Drug Labels

WEDNESDAY, Nov. 2 (HealthDay News) -- Under regulations effective Wednesday, the U.S. Food and Drug Administration will require drug manufacturers to submit package insert or labels to the federal agency in a new electronic format known as the structured product labeling (SPL).

More Information -- FDA

Physician's Briefing

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.